Antimicrobial peptides are considered to be one of the candidate antimicrobial agents for antibiotic-resistant bacterial infection in the future. The effects of antimicrobial peptide hBD3-CBD on Pseudomonas aeruginosa PA14 and PA14 ΔexsA were analyzed by the bactericidal effects, hemolysis assays, pyocyanin pigment productions, and virulence factor expressions (exoU, exoS, hcnA, and lasB). Pyocyanin production and virulence factor expressions are important features of the type III secretion system in Pseudomonas aeruginosa. HBD3-CBD killed PA14 and PA14 ΔexsA with similar efficiency; it lowered the hemolysis levels of PA14 and PA14 ΔexsA and reduced the pyocyanin production, biofilm formation, and exoU, exoS, and lasB expressions in PA14. Compared with PA14, PA14 ΔexsA showed a lower hemolysis effect, pyocyanin production, exoU, and lasB expressions. The effects of hBD3-CBD on the PA14 toxin secretion were similar to the changes in the type III secretion system mutant isolate PA14 ΔexsA. Our results demonstrated that the type III secretion system was involved in the biological functions on PA 14 from hBD3-CBD.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Izadpanah A, Gallo RL (2005) Antimicrobial peptides. J Am Acad Dermatol 52:381–390 quiz 391-382
Harder J, Glaser R, Schroder JM (2007) The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases. Endocr Metab Immune Disord Drug Targets 7:75–82
Dunsche A, Açil Y, Dommisch H, Siebert R, Schröder JM, Jepsen S (2002) The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 110:121–124
Dhople V, Krukemeyer A, Ramamoorthy A (2006) The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta 1758:1499–1512
Harder J, Bartels J, Christophers E, Schroder JM (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707–5713
Bassetti M, Vena A, Croxatto A et al (2018) How to manage Pseudomonas aeruginosa infections. Drugs Context 7:212527
Lin P, Li Y, Dong K, Li Q (2015) The antibacterial effects of an antimicrobial peptide human beta-defensin 3 fused with carbohydrate-binding domain on Pseudomonas aeruginosa PA14. Curr Microbiol 71:170–176
Beaudoin T, Stone TA, Glibowicka M et al (2018) Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms. Sci Rep 8:14728
Mohammed I, Said DG, Nubile M et al (2019) Cathelicidin-derived synthetic peptide improves therapeutic potential of vancomycin against. Front Microbiol 10:2190
Lombardi C, Tolchard J, Bouillot S et al (2019) Structural and functional characterization of the type three secretion system (T3SS) needle of Pseudomonas aeruginosa. Front Microbiol 10:573
Galle M, Carpentier I, Beyaert R (2012) Structure and function of the type III secretion system of Pseudomonas aeruginosa. Curr Protein Pept Sci 13:831–842
Sharma P, Guha S, Garg P et al (2018) Differential expression of antimicrobial peptides in corneal infection and regulation of antimicrobial peptides and reactive oxygen species by type III secretion system of Pseudomonas aeruginosa. Pathog Dis 76(1). https://doi.org/10.1093/femspd/fty001
Li Q, Zhou Y, Dong K et al (2010) Potential therapeutic efficacy of a bactericidal-immunomodulatory fusion peptide against methicillin-resistant Staphylococcus aureus skin infection. Appl Microbiol Biotechnol 86:305–309
Rossignol G, Merieau A, Guerillon J et al (2008) Involvement of a phospholipase C in the hemolytic activity of a clinical strain of Pseudomonas fluorescens. BMC Microbiol 8:189
Yang H, Shan Z, Kim J, Wu W, Lian W, Zeng L, Xing L, Jin S (2007) Regulatory role of PopN and its interacting partners in type III secretion of Pseudomonas aeruginosa. J Bacteriol 189:2599–2609
Essar DW, Eberly L, Hadero A, Crawford IP (1990) Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications. J Bacteriol 172:884–900
Berthelot P, Attree I, Plesiat P et al (2003) Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J Infect Dis 188:512–518
Gokalsin B, Sesal NC (2016) Lichen secondary metabolite evernic acid as potential quorum sensing inhibitor against Pseudomonas aeruginosa. World J Microbiol Biotechnol 32:150
Eleaume H, Jabbouri S (2004) Comparison of two standardisation methods in real-time quantitative RT-PCR to follow Staphylococcus aureus genes expression during in vitro growth. J Microbiol Methods 59:363–370
Gao N, Kumar A, Jyot J et al (2010) Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway. PLoS One 5:e9351
Beisswenger C, Bals R (2005) Functions of antimicrobial peptides in host defense and immunity. Curr Protein Pept Sci 6:255–264
Sechet E, Telford E, Bonamy C et al (2018) Natural molecules induce and synergize to boost expression of the human antimicrobial peptide β-defensin-3. Proc Natl Acad Sci U S A 115:E9869–e9878
Cody WL, Pritchett CL, Jones AK et al (2009) Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner. J Bacteriol 191:2993–3002
Deng X, Li M, Pan X et al (2017) Fis regulates type III secretion system by influencing the transcription of exsA in Pseudomonas aeruginosa strain PA14. Front Microbiol 8:669
Memariani H, Shahbazzadeh D, Ranjbar R et al (2017) Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. Chem Biol Drug Des 89:327–338
Li Q, Huang J, Guo H et al (2012) Bactericidal activity against meticillin-resistant Staphylococcus aureus of a novel eukaryotic therapeutic recombinant antimicrobial peptide. Int J Antimicrob Agents 39:496–499
Ho Sui SJ, Lo R, Fernandes AR et al (2012) Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence. Int J Antimicrob Agents 40:246–251
Sawa T, Shimizu M, Moriyama K et al (2014) Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review. Crit Care 18:668
Chowdhury N, Bagchi A (2016) Molecular insight into the activity of LasR protein from Pseudomonas aeruginosa in the regulation of virulence gene expression by this organism. Gene. 580:80–87
Rangel SM, Logan LK, Hauser AR (2014) The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia. MBio. 5:e01080–e01014
Roshani-Asl P, Rashidi N, Shokoohizadeh L, Zarei J (2018) Relationship among antibiotic resistance, biofilm formation and lasB gene in Pseudomonas Aeruginosa isolated from burn patients. Clin Lab 64:1477–1484
Yu H, He X, Xie W, Xiong J, Sheng H, Guo S, Huang C, Zhang D, Zhang K (2014) Elastase LasB of Pseudomonas aeruginosa promotes biofilm formation partly through rhamnolipid-mediated regulation. Can J Microbiol 60:227–235
Tettmann B, Niewerth C, Kirschhöfer F et al (2016) Enzyme-mediated quenching of the quinolone signal (PQS) promotes biofilm formation of by increasing Iron availability. Front Microbiol 7:1978
Brutinel ED, Vakulskas CA, Yahr TL (2009) Functional domains of ExsA, the transcriptional activator of the Pseudomonas aeruginosa type III secretion system. J Bacteriol 191:3811–3821
Shrestha M, Xiao Y, Robinson H et al (2015) Structural analysis of the regulatory domain of ExsA, a key transcriptional regulator of the type three secretion system in Pseudomonas aeruginosa. PLoS One 10:e0136533
Zaiou M (2007) Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med 85:317–329
Wu X, Li Z, Li X et al (2017) Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria. Drug Des Devel Ther 11:939–946
Li G, Lu S, Shen M et al (2017) Characterization and interstrain transfer of prophage pp3 of Pseudomonas aeruginosa. PLoS One 12:e0174429
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Responsible Editor: Tânia A. Tardelli Gomes.
About this article
Cite this article
Wu, Y., Liu, Y., Dong, K. et al. Effects of human β-defensin 3 fused with carbohydrate-binding domain on the function of type III secretion system in Pseudomonas aeruginosa PA14. Braz J Microbiol (2020) doi:10.1007/s42770-020-00223-2
- Antimicrobial peptide
- Pseudomonas aeruginosa